Market Cap • 20/20 Biolabs
AIDX
20/20 Biolabs, Inc., based in Rockville, Maryland, is a commercial-stage diagnostics company dedicated to improving health outcomes through early disease detection. The company leverages machine learning and advanced laboratory techniques to develop innovative testing solutions. Its primary focus is on its 'OneTest' platform, a multi-cancer screening tool that analyzes a panel of tumor biomarkers to help identify the risk of several types of cancer in their early, more treatable stages. In addition to cancer diagnostics, 20/20 Biolabs has expanded its portfolio to include rapid diagnostic tests and laboratory services, notably providing COVID-19 testing solutions and other respiratory panels. The company operates a CLIA-certified and CAP-accredited laboratory, ensuring high standards for its diagnostic offerings. By combining biological data with artificial intelligence, 20/20 Biolabs aims to provide clinicians and patients with actionable health insights, positioning itself at the intersection of biotechnology and digital health. The company's mission is to make early cancer detection more accessible and effective through the integration of data science and clinical diagnostics.
4,7M
Market Cap
Market capitalization, or "market cap", is the aggregate market value of a company represented in a dollar amount. Since it represents the “market” value of a company, it is computed based on the current market price (CMP) of its shares and the total number of outstanding shares.
1,6M
EV
Enterprise value (EV) measures a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt and any cash or cash equivalents on the company's balance sheet.
0,9
EV/Revenue
The enterprise value-to-revenue multiple (EV/R) is a measure of the value of a stock that compares a company's enterprise value to its revenue. EV/R is one of several fundamental indicators that investors use to determine whether a stock is priced fairly. The EV/R multiple is also often used to determine a company's valuation in the case of a potential acquisition. It's also called the enterprise value-to-sales multiple.
-0,4
EV/EBITDA
The enterprise value to earnings before interest, taxes, depreciation, and amortization ratio (EV/EBITDA) compares the value of a company—debt included—to the company's cash earnings less non-cash expenses. It's best to use the EV/EBITDA metric when comparing companies within the same industry or sector. Typically, when evaluating a company, an EV/EBITDA value below 10 is seen as healthy.
-0,4
EV/EBIT
It follows the same logic as the EV/EBITDA indicator, but instead of EBITDA, EBIT is used, which considers non-cash D&A expenses in the company's operating result.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!